Variant report

Variant	nsv892762
Chromosome Location	chr9:22630892-22680915
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:22642399-22642402	GM12878	blood:	n/a	n/a
2	BRCA1	chr9:22669815-22669872	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr9:22660568-22660768	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr9:22642450-22642606	A549	lung:	n/a	chr9:22642528-22642539
5	CEBPB	chr9:22642451-22642589	HepG2	liver:	n/a	chr9:22642528-22642539
6	CTCF	chr9:22635074-22635076	GM10248	blood:	n/a	n/a
7	CTCF	chr9:22641103-22641137	Lung_OC	lung:	n/a	n/a
8	CTCF	chr9:22665729-22665765	LNCaP	prostate:	n/a	n/a
9	CTCF	chr9:22660397-22660440	LNCaP	prostate:	n/a	n/a
10	CUX1	chr9:22657565-22657659	GM12878	blood:	n/a	n/a
11	FOS	chr9:22657771-22657919	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr9:22645958-22646232	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr9:22645966-22646219	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr9:22645983-22646206	MCF10A-Er-Src	breast:	n/a	n/a
15	FOS	chr9:22645904-22646258	MCF10A-Er-Src	breast:	n/a	n/a
16	FOXA2	chr9:22659205-22659563	A549	lung:	n/a	n/a
17	FOXA2	chr9:22659270-22659582	A549	lung:	n/a	n/a
18	JUN	chr9:22654893-22655133	HepG2	liver:	n/a	chr9:22655037-22655046 chr9:22655083-22655095 chr9:22655036-22655049
19	JUND	chr9:22654858-22655201	HepG2	liver:	n/a	chr9:22655037-22655046 chr9:22655083-22655095
20	NFYA	chr9:22668235-22668410	GM12878	blood:	n/a	n/a
21	POLR2A	chr9:22667579-22667860	MCF10A-Er-Src	breast:	n/a	n/a
22	POLR2A	chr9:22645301-22645836	MCF10A-Er-Src	breast:	n/a	n/a
23	POLR2A	chr9:22657628-22657915	MCF10A-Er-Src	breast:	n/a	n/a
24	POLR2A	chr9:22635669-22636033	MCF10A-Er-Src	breast:	n/a	n/a
25	POLR2A	chr9:22631593-22631786	MCF10A-Er-Src	breast:	n/a	n/a
26	POLR2A	chr9:22647966-22648073	GM12878	blood:	n/a	n/a
27	POLR2A	chr9:22648527-22648779	MCF10A-Er-Src	breast:	n/a	n/a
28	POLR2A	chr9:22638376-22638576	MCF10A-Er-Src	breast:	n/a	n/a
29	POLR2A	chr9:22655632-22655816	MCF10A-Er-Src	breast:	n/a	n/a
30	POLR2A	chr9:22633910-22634180	MCF10A-Er-Src	breast:	n/a	n/a
31	POLR2A	chr9:22658277-22658822	H1-hESC	embryonic stem cell:	n/a	n/a
32	POLR2A	chr9:22656395-22656401	GM12878	blood:	n/a	n/a
33	POLR2A	chr9:22672499-22672658	MCF10A-Er-Src	breast:	n/a	n/a
34	POLR2A	chr9:22669062-22669260	MCF10A-Er-Src	breast:	n/a	n/a
35	STAT3	chr9:22653655-22653783	MCF10A-Er-Src	breast:	n/a	n/a
36	STAT3	chr9:22654255-22654455	MCF10A-Er-Src	breast:	n/a	n/a
37	STAT3	chr9:22657812-22657955	MCF10A-Er-Src	breast:	n/a	chr9:22657866-22657874
38	ZNF143	chr9:22673461-22673473	H1-hESC	embryonic stem cell:	n/a	n/a
39	ZNF143	chr9:22669275-22669563	H1-hESC	embryonic stem cell:	n/a	n/a
40	ZNF263	chr9:22634424-22634880	HEK293-T-REx	kidney:	n/a	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CDKN2B-5	chr9:22651795-22652209	NONHSAT130440
2	lnc-DMRTA1-1	chr9:22674481-22674642	NONHSAT130443
3	lnc-CDKN2B-5	chr9:22636866-22636923	NONHSAT130440
4	lnc-DMRTA1-10	chr9:22664442-22664642	l_3742_chr9:22664441-22713435_adipose
5	lnc-DMRTA1-2	chr9:22674442-22674642	ENSG00000234840.1
6	lnc-DMRTA1-10	chr9:22672609-22672712	l_3742_chr9:22664441-22713435_adipose
7	lnc-DMRTA1-1	chr9:22674434-22674694	NONHSAT130441
8	lnc-DMRTA1-1	chr9:22646108-22646877	NONHSAT130441
9	lnc-DMRTA1-2	chr9:22646199-22646295	ENSG00000234840.1

Variant related genes	Relation type
ENSG00000234840	TF binding region

Extended variants
information (count: 1769 )
Associated
traits (count: 151 )

Variant overlapped rSNPs/rCNVs (count:1769 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1629774	chr9:22630892-22630893	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs535854300	chr9:22630936-22630937	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs143862751	chr9:22630978-22630979	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs2383233	chr9:22630989-22630990	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs536935057	chr9:22631071-22631072	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs557151930	chr9:22631123-22631124	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs562414968	chr9:22631148-22631149	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs199706488	chr9:22631197-22631198	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs371880493	chr9:22631199-22631200	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs61208423	chr9:22631219-22631220	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs148624760	chr9:22631282-22631283	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs552665130	chr9:22631307-22631308	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs572562155	chr9:22631319-22631320	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs541812560	chr9:22631322-22631323	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs538944622	chr9:22631348-22631349	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs191131701	chr9:22631395-22631396	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs551005162	chr9:22631413-22631414	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs575928053	chr9:22631419-22631420	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs375814603	chr9:22631423-22631424	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs544557696	chr9:22631431-22631432	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs551602	chr9:22631450-22631451	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs12555411	chr9:22631470-22631471	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs540791556	chr9:22631480-22631481	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs560573039	chr9:22631483-22631484	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs35429078	chr9:22631570-22631571	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs529367578	chr9:22631591-22631592	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs549396771	chr9:22631604-22631605	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs569140295	chr9:22631610-22631611	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs552317724	chr9:22631625-22631626	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs142057945	chr9:22631635-22631636	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs570377735	chr9:22631676-22631677	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs570542030	chr9:22631772-22631773	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs151177673	chr9:22631802-22631803	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs7030812	chr9:22631818-22631819	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs146988906	chr9:22631822-22631823	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs535184796	chr9:22631840-22631841	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs555370897	chr9:22631957-22631958	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs575154518	chr9:22631973-22631974	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs199630236	chr9:22636871-22636872	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
40	rs144967497	chr9:22640252-22640253	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs369475865	chr9:22640254-22640255	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs182992498	chr9:22640276-22640277	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs574016321	chr9:22640291-22640292	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs188691380	chr9:22640314-22640315	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs373047921	chr9:22640354-22640355	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs138888331	chr9:22640360-22640361	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs549011233	chr9:22640481-22640482	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs544838697	chr9:22640493-22640494	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs192687720	chr9:22640494-22640495	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs572042723	chr9:22640495-22640496	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:151)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Glioblastoma multiforme	21569311	CNVD
Myelofibrosis	22110671	CNVD
Ewing''s sarcoma	22429812	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	19435819	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Lung cancer	21911935	CNVD
Primary central nervous system lymphoma	21088137	CNVD
head and neck squamous cell carcinoma	21798897	CNVD
Cancer	21253487	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Glioblastoma multiforme	21922591	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Urothelial cell carcinoma	18451213	CNVD
Glioma	17123091	CNVD
Mental retardation	17124404	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Leukemia	19602459	CNVD
Acute monocytic leukemia	16498392	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Leukemia	18688285	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Glioma	20126413	CNVD
Melanoma	17363583	CNVD
Glioblastoma multiforme	19115005	CNVD
Glioblastoma multiforme	21138945	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Cancer	20581869	CNVD
Oral cancer	22144094	CNVD
Barrett''s syndrome	19417022	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	17237825	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Glioblastoma multiforme	21525872	CNVD

Chromatin state (count:133 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:22623800-22631000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr9:22629200-22631600	Enhancers	HUES48 Cell Line	embryonic stem cell
3	chr9:22629400-22632000	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr9:22630200-22631600	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr9:22630400-22631600	Enhancers	HUES6 Cell Line	embryonic stem cell
6	chr9:22630400-22631600	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr9:22630400-22631600	Enhancers	iPS-20b Cell Line	embryonic stem cell
8	chr9:22631000-22631600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr9:22631000-22631800	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr9:22631200-22631600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr9:22640200-22640800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr9:22643200-22644200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr9:22643200-22645800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr9:22643600-22644200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr9:22644200-22645200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr9:22644200-22645800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
17	chr9:22645200-22645800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr9:22645800-22646000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr9:22645800-22646000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr9:22645800-22646000	Enhancers	Skeletal Muscle Female	skeletal muscle
21	chr9:22645800-22646200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr9:22645800-22646200	Enhancers	Muscle Satellite Cultured Cells	--
23	chr9:22645800-22646200	Enhancers	NHDF-Ad	bronchial
24	chr9:22645800-22646800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr9:22646000-22646200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
26	chr9:22646000-22647000	Active TSS	Skeletal Muscle Male	skeletal muscle
27	chr9:22646000-22647400	Active TSS	Adipose Nuclei	Adipose
28	chr9:22646000-22647800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr9:22646000-22648400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr9:22646200-22646400	Enhancers	Skeletal Muscle Female	skeletal muscle
31	chr9:22646200-22646600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr9:22646200-22646600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
33	chr9:22646200-22646600	Active TSS	NHDF-Ad	bronchial
34	chr9:22646200-22647000	Active TSS	Duodenum Smooth Muscle	Duodenum
35	chr9:22646400-22646600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
36	chr9:22646400-22647000	Active TSS	NHLF	lung
37	chr9:22646600-22646800	Active TSS	Muscle Satellite Cultured Cells	--
38	chr9:22646600-22647200	Active TSS	Skeletal Muscle Female	skeletal muscle
39	chr9:22646600-22649400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr9:22646800-22649000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr9:22647000-22649200	Weak transcription	Skeletal Muscle Male	skeletal muscle
42	chr9:22647200-22649600	Weak transcription	Skeletal Muscle Female	skeletal muscle
43	chr9:22647400-22651000	Weak transcription	Adipose Nuclei	Adipose
44	chr9:22647800-22648200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr9:22648200-22648400	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr9:22648400-22648800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr9:22648400-22649200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr9:22648800-22649200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr9:22649000-22650000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr9:22649200-22649400	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links